ABBV's Improving Oncology Sales Poise It Well for Long-Term GrowthZacks Investment Research • 08/22/25
AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia AreataPRNewsWire • 08/21/25
2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or LongerThe Motley Fool • 08/21/25
If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/18/25
My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 BuysSeeking Alpha • 08/13/25
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.PRNewsWire • 08/12/25
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%Benzinga • 08/08/25
Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and TransparencyPRNewsWire • 08/05/25
How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?Zacks Investment Research • 08/04/25
If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/03/25
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challengesWSJ • 08/01/25